Analysis of the use of nitroglycerin in pre-hospital procedure by medical rescue teams in patients with acute coronary syndrome (ACS STEMI), with particular regard to a closed right coronary artery

Grzegorz Wójcik, Maciej Lewandowski, Marek Myślak, Paulina Wójcik, Magdalena Bikowska

Abstract


Introduction: Currently, cardiological societies and associations do not recommend the use of nitroglycerin in patients with acute coronary syndrome ST-elevation myocardial infarction (ACS STEMI). However, an analysis of medical rescue practice shows that this medicine is still being used.
The aim of this study is to conduct a correlation analysis of the use of nitroglycerin by medical rescue teams (MRT) in patients with ACS STEMI and its impact on selected biochemical parameters.
Materials and methods: The study group consisted of 312 patients. Data for these patients over a period of 8 years (2009–2017) was analysed. A retrospective study of the dispatch orders for MRT, including primary transport was conducted.
Results: Coronary angiography revealed a closed right coronary artery (RCA) in 312 patients. In 210 patients, the MRT administered nitroglycerin during pre-hospital procedure, where RCA closure was confirmed in a coronary angiography. After administering nitroglycerin and discovering an RCA occlusion, more favourable results of biochemical parameters and statistical differences between the groups in Killip class were shown (p = 0.022). Lower values of Troponin I and creatine kinase–myocardial band (CK-MB) max. parameters as well as higher cardiac ejection fraction (left ventricular ejection fraction – LVEF) were observed after administering nitroglycerin (no statistical significance).
Conclusions: It was not clearly demonstrated that the use or non-use of nitroglycerin at the pre-hospital stage (1–2 doses of the drug) negatively affected the patient’s condition. At the same time, it was shown that the use of nitroglycerin at the pre-hospital stage, and the lack of nitroglycerin administration at hospital resulted in lower, selected biochemical parameters, and that theuse of nitroglycerin had a significant impact on the Killip class.

Keywords


acute coronary syndrome; emergency medicine; nitroglycerin; right ventricular heart failure

Full Text:

PDF

References


Ustawa dnia 8 września 2006 r. o Państwowym Ratownictwie Medycznym. Dz.U. 2006 Nr 191, poz. 1410.

Steg G, James SK, Atar D, Badano LP, Lundquist CB, Borger MA, et al. Wytyczne ESC dotyczące postępowania w ostrym zawale serca z przetrwałym uniesieniem odcinka ST. Kardiol Pol 2012;70 Suppl 6:255-572.

Widimsky P, Zelizko M, Jansky M, Tousek F, Holm F, Aschermann M. The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry. Int J Cardiol 2007;119(2):212-9.

Bakhai A, Iñiguez A, Ferrieres J, Schmitt C, Sartral M, Belger M, et al. Treatment patterns in acute coronary syndrome patients in the United Kingdom undergoing PCI. EuroIntervention 2011;6(8):992-6.

Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Guidelines regarding procedures in acute coronary arrest STEMI. Kardiol Pol 2009;67 Supl. 2:53-98.

Pfisterer M. Right ventricular involvement in myocardial infarction and cardiogenic shock. Lancet 2003;362(9381):392-4.

Kumar A, Abdel-Aty H, Kriedemann I, Schulz-Menger J, Gross CM, Dietz R, et al. Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. J Am Coll Cardiol 2006;48(10):1969-76.

Stachowiak P, Wójcik G, Kazimierczak A, Clark J, Gorący J, Kornacewicz-Jach Z. Comparison of transport methods for patients with ST-elevation myocardial infarction to a percutaneous coronary intervention centre and determination of factors influencing long-term mortality. Int J Cardiol 2016;202:135-7.

Krstic N, Pavlović M, Koracevic G, Stojkovic A, Pavlovic S. Predictive markers for one-year outcome in patients with STEMI treated with primary parcutaneus coronary intervention (PCI). HealthMed 2012;6(3):916-25.

Smarż K, Zaborska B. Zawał prawej komory serca i jego następstwa. Post Nauk Med 2010;12:968-73.

Clemmensen P, Schoos MM, Lindholm MG, Rasmussen LS, Steinmetz J, Hesselfeldt R, et al. Pre-hospital diagnosis and transfer of patients with acute myocardial infarction – a decade long experience from one of Europe’s largest STEMI networks. J Electrocardiol 2013;46(6):546-52.

Rasmussen MB, Frost L, Stengaard C, Brorholt-Petersen JU, Dodt KK, Søndergaard HM, et al. Diagnostic performance and system delay using telemedicine for prehospital diagnosis in triaging and treatment of STEMI. Heart 2014;100(9):711-5.

Ibanez B, James S, Agawell S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017. Wytyczne ESC dotyczące postępowania w ostrym zawale serca z uniesieniem odcinka ST w 2017 roku. Kardiol Pol 2018;76(2):229-313.




DOI: https://doi.org/10.21164/pomjlifesci.765

Copyright (c) 2021 Grzegorz Wójcik, Maciej Lewandowski, Marek Myślak, Paulina Wójcik, Magdalena Bikowska

License URL: https://creativecommons.org/licenses/by-nc-nd/3.0/pl/